GlassScriptPhysician profile
Saif U Farooq
NPI 1518007632
$1,710.11
in general payments reported to CMS, 2019-2025
16 companies · $1,193 in 2025
The $1,193 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.32 · 2021: $19.20 · 2022: $153 · 2023: $48.61 · 2024: $264 · 2025: $1,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $833 · Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $832.56 |
| Food and Beverage | $673.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $878.69 | 2025 | |
| Insmed, INC. | $210.29 | 2022-2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $200.40 | 2022-2025 | Nucala, Trelegy Ellipta |
| Baxter Healthcare | $109.58 | 2024 | Hillrom - Monarch Airway Clearance System |
| Astrazeneca Pharmaceuticals LP | $43.13 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.23 | 2022 | |
| Electromed, INC. | $36.97 | 2024 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $28.81 | 2022 | |
| Genzyme Corporation | $28.42 | 2025 | |
| Pfizer INC. | $27.08 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $22.90 | 2023 | Dupixent |
| Mylan Specialty L.P. | $22.60 | 2022 | |
| Fisher & Paykel Healthcare INC | $19.20 | 2021 | |
| Amgen INC. | $15.50 | 2025 | Tezspire |
| Inogen, INC. | $13.01 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $11.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saif Farooq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.